Presentation at the 102nd Scientific Assembly and Annual Meeting of the Radiological Society of North America (RSNA) in Chicago, IL by Dr. Haydar Celik, Ph.D. (NIH Clinical Center) entitled "RFA Duration per Tumor Volume May Correlate With Overall Survival in Patients Treated with RFA plus Lyso Thermosensitive Liposomal Doxorubicin (LTLD)"

Nov 28, 2016




Share This